NMR based stable isotope resolved metabolomics was used for the metabolic characterization of renal cell carcinoma (RCC) patient-derived xenografts (PDXs) and their derived tissue slice cultures (TSCs). Targeted metabolomics and [U-13C] glucose-labeling studies indicate metabolic heterogeneity among PDXs of various pathologic and clinical stages. Both PDXs and TSCs exhibit high glycolytic rate and low TCA activity characteristic of RCC. However, there is variability in glycolytic rate and TCA activity among different PDXs and their corresponding TSCs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords